
Opinion|Videos|April 4, 2025
Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Experts discuss innovations and advancements in bispecific antibodies that could transform their use in the next 5 years.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What innovations or advancements in bispecific antibodies could transform their use in the next 5 years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
2
Long-Term Trial Shows Durable Efficacy, QOL Gains With Nirogacestat in Desmoid Tumors
3
Top 5 Most-Read Multiple Sclerosis Articles of 2025
4
Top 5 Trending FDA Approvals of 2025
5









































